Back to Screener

Healthcare

Ligand Pharmaceuticals Incorporated(LGND)

Live Price

Offline

$295.92

+3.86% today

Window Change

+20.29%

Window

May 5, 2026 โ†’ Jun 23, 2026

Market Cap
$4.68B
Revenue Growth
+60.4%
EPS Growth
+3027.3%
Dividend Yield
0.0%
Sparse coverage

Historical coverage is still filling in

This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.

Coverage: 29 bars ยท May 5, 2026 โ†’ Jun 23, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Ligand Pharmaceuticals Incorporated (LGND) is a Healthcare stock with a market cap of $4.68B and listed on NASDAQ. The stock last traded around $295.92 and up 20.3% across the available one-year price window (May 5, 2026 โ†’ Jun 23, 2026). Baseline metrics include revenue growth of +60.4%, EPS growth of +3027.3%, a dividend yield of 0.0%. What stands out right now is revenue +60.4%, EPS +3027.3%, free cash flow -36.8% with operating margin 17.6% and ROIC 2.4%. Valuation already assumes a fairly strong business story at P/E 37.2 and price/sales 17.5. Stock Foundry combines LGND price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

LGND vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

LGND

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

LGND Max Drawdown

-9.55%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for LGND and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 14, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 14, 26
โ€”
Est 1.84
โ€”
โ€”
Est 59099.2B
โ€”
May 14
โ€”
Feb 26, 26
โœ“
2.02
Est 1.46
+38.4%
59666.0B
Est 55588.9B
+7.3%
Feb 26
โ€”
Nov 6, 25
โœ“
3.09
Est 1.97
+56.9%
115461.0B
Est 55588.9B
+107.7%
Nov 6
โ€”
Aug 7, 25
โœ“
1.60
Est 1.54
+3.9%
47627.0B
Est 52830.9B
-9.8%
Aug 7
โ€”
May 8, 25
โœ“
1.33
Est 1.30
+2.3%
45333.0B
Est 44304.8B
+2.3%
May 8
โ€”
Feb 27, 25
โœ—
-1.64
Est 1.37
-219.7%
42812.0B
Est 35306.3B
+21.3%
Feb 27
โ€”
Nov 7, 24
โœ—
-0.39
Est 0.75
-152.0%
51812.0B
Est 39011.6B
+32.8%
Nov 7
โ€”
Aug 6, 24
โœ“
1.40
Est 1.10
+27.3%
41531.0B
Est 32860.0B
+26.4%
Aug 6
โ€”
May 7, 24
โœ“
1.20
Est 1.13
+6.2%
30978.0B
Est 27920.0B
+10.9%
May 7
โ€”
Feb 27, 24
โœ“
1.05
Est 0.58
+81.0%
28101.0B
Est 25720.0B
+9.3%
Feb 27
โ€”
Nov 8, 23
โœ“
1.02
Est 0.68
+50.0%
32868.0B
Est 27190.0B
+20.9%
Nov 8
โ€”
Aug 8, 23
โœ“
1.42
Est 0.76
+86.8%
26366.0B
Est 25730.0B
+2.5%
Aug 8
โ€”
May 4, 23
โœ“
2.28
Est 0.89
+156.2%
43979.0B
Est 34040.0B
+29.2%
May 4
โ€”
Feb 22, 23
โœ“
1.36
Est 1.23
+10.6%
50382.0B
Est 44091.0B
+14.3%
Feb 22
โ€”
Nov 7, 22
โœ—
0.41
Est 0.45
-8.9%
66088.0B
Est 38323.0B
+72.5%
Nov 7
โ€”
Aug 8, 22
โœ—
0.34
Est 0.54
-37.0%
57419.0B
Est 37734.8B
+52.2%
Aug 8
โ€”
May 4, 22
โœ—
0.58
Est 0.61
-4.9%
45693.0B
Est 34209.2B
+33.6%
May 4
โ€”
Feb 17, 22
โœ“
1.80
Est 1.38
+30.4%
72473.0B
Est 65088.2B
+11.3%
Feb 17
โ€”
Nov 9, 21
โœ“
1.58
Est 1.02
+54.9%
64835.0B
Est 53269.6B
+21.7%
Nov 9
โ€”
Jul 29, 21
โœ“
1.63
Est 1.36
+19.9%
84675.0B
Est 70490.0B
+20.1%
Jul 29
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener